Study findings indicated a transition from IV to enteral triazole therapy as a feasible option for pediatric patients with invasive candidiasis.

The Food and Drug Administration (FDA) has approved Ryoncil ® (remestemcel-L-rknd) for the treatment of steroid-refractory acute graft vs host disease (SR-aGvHD) in pediatric patients 2 months of age ...

Pediatric foot deformity is a term that includes a range of conditions that may affect the bones, tendons, and muscles of the foot. Among those most frequently treated at HSS are cavus foot, tarsal ...

A procalcitonin-guided algorithm does not reduce the length of intravenous antibiotic treatment significantly in children ...

Below is a review of novel drug and biological products approved by the Food and Drug Administration (FDA) in 2024. The list includes several groundbreaking therapies that are expected to change the ...

A groundbreaking UK study in The Lancet has examined whether an additional blood test called procalcitonin (PCT) could safely shorten the time children spend on intravenous (IV) antibiotics in ...

An 11-year-old boy overcomes Guillain-Barré syndrome, a rare neurological disorder, with timely treatment, intensive care, ...

The typical suspects of cold and flu season: norovirus, flu and RSV, COVID-19 have been making people sick. However, doctors ...

The Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn disease in adults.

Prevalence of abusive fractures of the hands, feet, spine, or pelvis on skeletal survey: perhaps "uncommon" is more common than suggested.

Data from the Minnesota Department of Health shows influenza levels remain significantly higher than the peaks recorded ...

Antibiotic management of acute uncomplicated appendicitis among children was inferior to appendectomy, a randomized ...